Evaluation of OX40 receptor density, influence of IgG Isotype and dosing paradigm in anti-OX40-mediated efficacy and biomarker responses with PD-1 blockade
Jackson, H., Bhattacharya, S., Bojczuk, P., Kilian, D., Seestaller Wehr, L., Hahn, A., Shi, H., Bi, M., Adam, M., Jing, J., Morley, P., Hopson, C., Paul, E., Hoos, A., Smothers, J., Srinivasan, R., Yanamandra, N.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Preclinical evaluation of a non-depleting, first-in-class humanized IgG4 agonist anti-ICOS antibody
Brett, S., Yadavilli, S., Seestaller-Wehr, L., Bhattacharya, S., Jackson, H., Bi, M., Willoughby, J., Zhang, T., Liu, Y.-B., Katlinskaya, Y.K., Shi, H., Jing, J., Hahn, A., Speller, S., David Figueroa, D., Yu, J., Olive, D., Cragg, M., Mayes, P., Hoos, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
PF558 THE ANTI‐BCMA ANTIBODY‐DRUG CONJUGATE GSK2857916 DRIVES IMMUNOGENIC CELL DEATH AND IMMUNE‐MEDIATED ANTI‐TUMOR RESPONSES, AND IN COMBINATION WITH AN OX40 AGONIST POTENTIATES IN VIVO ACTIVITY
Montes De Oca, R., Bhattacharya, S., Vitali, N., Patel, K., Kaczynski, H., Shi, H.Z., Blackwell, C., Seestaller‐Wehr, L., Cooper, D., Jackson, H., Tsvetkov, L., Kepp, O., Creighton‐Gutteridge, M., Hopson, C., Yang, J., Kroemer, G., Mayes, P., Shelton, C., Alavi, A., Hoos, A.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses In Vivo
Montes de Oca, Rocio, Alavi, Alireza S, Vitali, Nick, Bhattacharya, Sabyasachi, Blackwell, Christina, Patel, Krupa, Seestaller-Wehr, Laura, Kaczynski, Heather, Shi, Hong, Dobrzynski, Eric, Obert, Leslie, Tsvetkov, Lyuben, Cooper, David C, Jackson, Heather, Bojczuk, Paul, Forveille, Sabrina, Kepp, Oliver, Sauvat, Allan, Kroemer, Guido, Creighton-Gutteridge, Mark, Yang, Jingsong, Hopson, Chris, Yanamandra, Niranjan, Shelton, Christopher, Mayes, Patrick, Opalinska, Joanna, Barnette, Mary, Srinivasan, Roopa, Smothers, James, Hoos, Axel
Published in Molecular cancer therapeutics (01.10.2021)
Published in Molecular cancer therapeutics (01.10.2021)
Get full text
Journal Article
1192PEvaluation of OX40 receptor density, influence of IgG Isotype and dosing paradigm in anti-OX40-mediated efficacy and biomarker responses with PD-1 blockade
Jackson, H, Bhattacharya, S, Bojczuk, P, Kilian, D, Seestaller Wehr, L, Hahn, A, Shi, H, Bi, M, Adam, M, Jing, J, Morley, P, Hopson, C, Paul, E, Hoos, A, Smothers, J, Srinivasan, R, Yanamandra, N
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1840PPreclinical evaluation of a non-depleting, first-in-class humanized IgG4 agonist anti-ICOS antibody
Brett, S, Yadavilli, S, Seestaller-Wehr, L, Bhattacharya, S, Jackson, H, Bi, M, Willoughby, J, Zhang, T, Liu, Y-B, Katlinskaya, Y K, Shi, H, Jing, J, Hahn, A, Speller, S, David Figueroa, D, Yu, J, Olive, D, Cragg, M, Mayes, P, Hoos, A
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
The Orphan Receptor Tyrosine Kinase Ror2 Modulates Canonical Wnt Signaling in Osteoblastic Cells
Billiard, Julia, Way, Deana S, Seestaller-Wehr, Laura M, Moran, Robert A, Mangine, Annamarie, Bodine, Peter V. N
Published in Molecular endocrinology (Baltimore, Md.) (01.01.2005)
Published in Molecular endocrinology (Baltimore, Md.) (01.01.2005)
Get full text
Journal Article